로딩 중…
지수 로딩 중…
Alumis Inc. Common Stock
ALMS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$26.12-7.54%
2026-08-03
Financials
Valuation Metrics
Alumis Inc. Common Stock's Market Cap is $3.33B. At end of 2025 it was $1.02B. Ranked #1694 of 3,112 in US market (top 54%), #604 of 1,445 on NASDAQ (top 42%), #100 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.33B | US#1,694/3,112 Sec#100/269 |
| Revenue | $8M | US#2,926/3,112 Sec#182/269 |
| Net Income | $-237M | US—/3,112 Sec—/269 |
| Total Assets | $672M | US#2,625/3,112 Sec#128/269 |
| Net Assets | $567M | US#2,168/3,112 Sec#102/269 |
| Value | ||
| P/B | 5.87x | US#2,294/3,112 Sec#153/269 |
| P/S | 396.35x | US#2,933/3,112 Sec#193/269 |
| FCF Yield | -11.32% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -41.87% | US#2,703/3,112 Sec#157/269 |
| ROA | -35.35% | US#2,907/3,112 Sec#178/269 |
| Op. Margin | -5364.02% | US#2,952/3,112 Sec#192/269 |
| Revenue Growth | -89.99% | US#2,927/3,112 Sec#179/269 |
| Financial Health | ||
| Debt Ratio | 18.44% | US#200/3,112 Sec#75/269 |
| Total Debt | $36M | US#2,610/3,112 Sec#161/269 |
| FCF | $-377M | US#2,807/3,112 Sec#248/269 |
| Cash | $64M | US#2,468/3,112 Sec#209/269 |
| Current Ratio | 7.51x | US#313/3,112 Sec#101/269 |
| Performance | ||
| 1Y Return | 532.45% | US#11/3,112 Sec#5/269 |
| 1M Return | -1.43% | US#1,847/3,112 Sec#93/269 |
| From 52W High | -16.68% | US#1,517/3,112 Sec#91/269 |
| 1Y MDD | -36.66% | US#1,786/3,112 Sec#126/269 |
| Trading | ||
| Volume | 1,386,837 shares | US#1,188/3,112 Sec#114/269 |
| Trading Value | $37M | US#1,587/3,112 Sec#103/269 |
| Per Share | ||
| EPS | $-2.32 | US—/3,112 Sec—/269 |
| BPS | $2.88 | US#2,433/3,112 Sec#163/269 |